Barclays PLC Verastem, Inc. Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
SELL
$0.33 - $10.44 $4,047 - $128,046
-12,265 Reduced 49.05%
12,740 $5,000
Q3 2022

Nov 03, 2022
BUY
$0.92 - $11.16 $9,896 - $120,048
10,757 Added 75.5%
25,005 $21,000
Q2 2022

Aug 12, 2022
SELL
$1.02 - $1.83 $28,378 - $50,914
-27,822 Reduced 66.13%
14,248 $16,000
Q1 2022

May 16, 2022
SELL
$1.06 - $2.1 $177,188 - $351,033
-167,159 Reduced 79.89%
42,070 $60,000
Q4 2021

Feb 14, 2022
BUY
$2.05 - $3.2 $281,844 - $439,952
137,485 Added 191.63%
209,229 $429,000
Q3 2021

Nov 09, 2021
SELL
$2.54 - $4.07 $1,651 - $2,645
-650 Reduced 0.9%
71,744 $220,000
Q2 2021

Aug 13, 2021
SELL
$2.57 - $4.85 $183,071 - $345,484
-71,234 Reduced 49.6%
72,394 $295,000
Q1 2021

May 13, 2021
BUY
$1.9 - $2.82 $166,759 - $247,505
87,768 Added 157.12%
143,628 $355,000
Q4 2020

Feb 11, 2021
SELL
$1.15 - $2.4 $25,768 - $53,776
-22,407 Reduced 28.63%
55,860 $119,000
Q3 2020

Nov 12, 2020
SELL
$1.11 - $1.68 $22,077 - $33,415
-19,890 Reduced 20.26%
78,267 $95,000
Q2 2020

Aug 12, 2020
BUY
$1.69 - $4.2 $165,885 - $412,259
98,157 New
98,157 $168,000
Q1 2020

May 13, 2020
SELL
$1.26 - $3.38 $565 - $1,517
-449 Closed
0 $0
Q4 2019

Feb 10, 2020
SELL
$0.86 - $1.44 $5,486 - $9,187
-6,380 Reduced 93.43%
449 $1,000
Q3 2019

Nov 14, 2019
SELL
$1.21 - $1.59 $223,828 - $294,121
-184,982 Reduced 96.44%
6,829 $9,000
Q2 2019

Aug 14, 2019
BUY
$1.25 - $3.14 $164,411 - $413,001
131,529 Added 218.19%
191,811 $289,000
Q1 2019

May 15, 2019
BUY
$2.79 - $4.09 $85,507 - $125,350
30,648 Added 103.42%
60,282 $178,000
Q4 2018

Feb 14, 2019
SELL
$3.23 - $7.01 $96,912 - $210,328
-30,004 Reduced 50.31%
29,634 $99,000
Q3 2018

Nov 14, 2018
BUY
$6.86 - $9.97 $382,506 - $555,917
55,759 Added 1437.46%
59,638 $432,000
Q2 2018

Aug 14, 2018
BUY
$2.88 - $8.67 $11,171 - $33,630
3,879 New
3,879 $27,000
Q1 2018

May 15, 2018
SELL
$2.92 - $3.81 $102 - $133
-35 Closed
0 $0
Q4 2017

Feb 14, 2018
SELL
$2.99 - $4.85 $2,586 - $4,195
-865 Reduced 96.11%
35 $0
Q3 2017

Nov 14, 2017
BUY
$3.01 - $5.41 $2,709 - $4,869
900
900 $4,000

Others Institutions Holding VSTM

# of Institutions
5
Shares Held
297K
Call Options Held
0
Put Options Held
0
View Full List

About Verastem, Inc.

VSTM Quotes by TradingView
  • Ticker VSTM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 210,000,000
  • Market Cap $1.12B
  • Description
  • Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...
More about VSTM
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email